• Ségolène Mrozek, Mohamed Srairi, Fouad Marhar, Clément Delmas, François Gaussiat, Timothée Abaziou, Claire Larcher, Vincent Atthar, Rémi Menut, Olivier Fourcade, and Thomas Geeraerts.
• Department of Anesthesia and Intensive Care, University Hospital of Toulouse, University Toulouse 3 Paul Sabatier, 31000 Toulouse, France. Electronic address: mrozek.s@chu-toulouse.fr.
• Heart Lung. 2016 Sep 1; 45 (5): 406-8.

BackgroundTakotsubo cardiomyopathy can occur at the early phase of severe acute brain injuries. In the case of cardiac output decrease or shock, the optimal treatment is still a matter of debate. Due to massive stress hormone release, the infusion of catecholamines may have limited effects and may even aggravate cardiac failure. Other inotropic agents may be an option. Levosimendan has been shown to have potential beneficial effects in this setting, although milrinone has not been studied.MethodsWe report a case of a young female presenting with inverted Takotsubo cardiomyopathy syndrome after severe traumatic brain injury.ResultsDue to hemodynamic instability and increasing levels of infused norepinephrine, dobutamine infusion was begun but rapidly stopped due to tachyarrhythmia. Milrinone infusion stabilized the patient's hemodynamic status and improved cardiac output without deleterious effects.ConclusionMilrinone could be a good alternative when inotropes are required in Takotsubo cardiomyopathy and when dobutamine infusion is associated with tachyarrhythmia.Copyright © 2016 Elsevier Inc. All rights reserved.

22 keywords...

hide…